Cerity Partners
DXCM icon

Cerity Partners’s DexCom DXCM Stock Holding History

Cerity Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.12M Buy
145,239
+7,253
+5% +$505K 0.01% 739
2025
Q4 		$9.16M Buy
137,986
+17,571
+15% +$1.14M 0.01% 679
2025
Q3 		$8.1M Buy
120,415
+60,241
+100% +$4.77M 0.01% 667
2025
Q2 		$5.25M Sell
60,174
-9,427
-14% -$739K 0.01% 784
2025
Q1 		$4.75M Buy
69,601
+2,711
+4% +$221K 0.01% 752
2024
Q4 		$5.1M Buy
66,890
+6,840
+11% +$506K 0.01% 705
2024
Q3 		$4.03M Buy
60,050
+39,344
+190% +$3.23M 0.01% 796
2024
Q2 		$2.35M Sell
20,706
-5,578
-21% -$705K 0.01% 846
2024
Q1 		$3.65M Sell
26,284
-437,689
-94% -$55M 0.01% 758
2023
Q4 		$1.4M Buy
463,973
+456,097
+5,791% +$46.6M ﹤0.01% 880
2023
Q3 		$735K Sell
7,876
-8,705
-52% -$981K ﹤0.01% 847
2023
Q2 		$2.13M Buy
16,581
+3,673
+28% +$444K 0.01% 713
2023
Q1 		$1.5M Buy
12,908
+155
+1% +$17.4K ﹤0.01% 814
2022
Q4 		$1.44M Buy
12,753
+5,338
+72% +$586K 0.01% 600
2022
Q3 		$597K Sell
7,415
-288
-4% -$24.4K 0.01% 647
2022
Q2 		$575K Buy
7,703
+1,911
+33% +$174K 0.01% 704
2022
Q1 		$743K Sell
5,792
-2,248
-28% -$246K 0.01% 498
2021
Q4 		$1.08M Buy
8,040
+2,608
+48% +$375K 0.02% 428
2021
Q3 		$743K Sell
5,432
-132
-2% -$16.6K 0.02% 399
2021
Q2 		$594K Buy
5,564
+64
+1% +$6.15K 0.01% 441
2021
Q1 		$494K Buy
5,500
+692
+14% +$65K 0.01% 450
2020
Q4 		$444K Buy
4,808
+36
+0.8% +$3.21K 0.01% 433
2020
Q3 		$492K Buy
4,772
+1,368
+40% +$143K 0.02% 324
2020
Q2 		$345K Sell
3,404
-424
-11% -$37.9K 0.02% 330
2020
Q1 		$258K Buy
3,828
+28
+0.7% +$1.74K 0.02% 370
2019
Q4 		$208K Buy
+3,800
New +$180K 0.01% 496
2019
Q1 		– Sell
-9,592
Closed -$287K – 541
2018
Q4 		$287K Buy
9,592
+3,920
+69% +$124K 0.02% 411
2018
Q3 		$203K Buy
+5,672
New +$176K 0.01% 511

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cerity Partners's DXCM Position: Q1 2026 in Review

Cerity Partners increased its DexCom (DXCM) stake by 5.3% in Q1 2026, buying an estimated $505K and bringing the position to 145,239 shares worth $9.12M. The position accounts for 0.01% of the portfolio, ranked #739.

Cerity Partners first reported a position in DXCM in Q3 2018 and has held it in 28 quarters since. The position peaked at $9.16M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Cerity Partners held 145,239 shares of DexCom worth $9.12M as of Q1 2026.
  • Cerity Partners bought 7,253 DexCom shares in Q1 2026, an estimated $505K.
  • DexCom made up 0.01% of Cerity Partners's portfolio in Q1 2026, its #739 holding.
  • Cerity Partners first reported a position in DexCom in Q3 2018 and has held it in 28 quarters since.
  • Cerity Partners's DexCom position peaked at $9.16M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.